Showing posts with label Identifying. Show all posts
Showing posts with label Identifying. Show all posts

Monday, March 28, 2011

ABMS Board Certification Data A Proven Tool In Identifying The Most Qualified Physician Specialists To Assist In An Emergency

Error in deserializing body of reply message for operation 'Translate'. The maximum string content length quota (8192) has been exceeded while reading XML data. This quota may be increased by changing the MaxStringContentLength property on the XmlDictionaryReaderQuotas object used when creating the XML reader. Line 1, position 8654.

Main Category: Public Health
Also Included In: Aid / Disasters
Article Date: 21 Mar 2011 - 4:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Over the years, Board Certification data provided by the American Board of Medical Specialties (ABMS) has played a crucial role in verifying those physicians who are Board Certified by an ABMS Member Board, and the information has been accessed by state and federal officials in emergency situations so victims can receive immediate quality care from the most qualified specialists. Currently, 32 states/jurisdictions rely on ABMS Board Certification data and have incorporated it into their Emergency System for Advance Registration of Volunteer Health Professionals (ESAR-VHP), a federal program created to support states and territories in establishing standardized volunteer registration programs for disasters and public health and medical emergencies, so that they can be prepared to direct victims to medical help at a moment's notice. The program, administered on the state level, verifies the identification and credentials of health professionals so they can respond more quickly when a disaster strikes. By registering through ESAR-VHP, volunteers' identities, licenses, credentials, accreditations and hospital privileges are all verified in advance, which saves valuable time in emergencies.

"Providing information to the public that assures them of a physician's qualifications was one of the original purposes of ABMS, and remains equally as important today."

"Board Certification goes above and beyond basic medical licensure, and shows that a physician meets nationally recognized standards for education, knowledge, experience and skills to provide high quality care in a specific medical specialty, which can be particularly useful during emergencies when every second is critical," said Kevin B. Weiss, ABMS President and CEO. "Providing information to the public that assures them of a physician's qualifications was one of the original purposes of ABMS, and remains equally as important today."

ABMS Board Certification data has on several occasions proved its usefulness in helping the public gain access to highly qualified physicians in the midst of some of our country's most challenging moments. In 2005, the U.S. Department of Health and Human Services electronically accessed ABMS Board Certification data for the emergency verification of volunteers in the wake of Hurricane Katrina. ABMS Board Certification data has also been used to assist in the aftermath of the 2007 Minneapolis bridge collapse and the 2009 H1N1 flu pandemic, and was even kept on hand as a precautionary measure during the 2009 Presidential Inauguration. In addition to the effectiveness it has served in these capacities, ABMS Board Certification data can also be used to assist victims of other types of disasters such as tornadoes, oil spills, wildfires or acts of terrorism, and continues to expand to other organizations that need to verify credentials after a disaster or tragedy.

Besides the value it provides in emergencies, ABMS Board Certification data has been referenced by entities such as health care organizations, insurance companies, law firms, recruiters and research organizations. Initially offered in a print directory, information on the 750,000-plus physicians who are Board Certified by an ABMS Member Board today is contained in a centralized database maintained by ABMS that is circulated through its licensees for professional use and can be accessed with a simple click of a mouse, a feature that can prove to be a life-saver in the event of an emergency.

"As specialty medicine expanded and the number of certifying boards grew, information on Board Certification quickly became an important part of a physician's profile," said Dr. Weiss. "While a physician does not need to be Board Certified in order to practice medicine, Board Certification granted by an ABMS Member Board is a nationally recognized credential held in high regard by the health care industry and relied upon by health plans, payers and policy makers as a benchmark for assessing a doctor's qualifications. Board Certification information provided by ABMS is considered a 'gold standard' because of its credibility and quality."

By 2005, many medium to larger organizations that credential and privilege physicians were asking for products and services to streamline the credentials verification and application management process, reduce costs and create efficient processes. In response, ABMS launched ABMS Direct Connect Select™, a new eXtensible Mark-up Language (XML) Web service that allows credentialing professionals and emergency certification personnel to quickly and efficiently conduct electronic Primary Source Verification of physician specialty certification in the ABMS database through authorized credentialing systems.

Quick, efficient access to primary source physician certification information is important to emergency response teams who must verify the credentials of the many physicians who volunteer after a natural disaster or other major event that impacts the public's health. The initial roll-out of the ABMS Direct Connect Select™ service, which was launched one month before the first of the Gulf Coast hurricanes, was part of a state-based initiative to develop an emergency credentialing system.

"The fact that ABMS Board Certification data is looked up to by government officials at the state and federal levels is a testament to its reliability and the value it serves," said Dr. Weiss. "ABMS remains committed in its efforts to help the public find access to good, quality doctors who are highly effective in treating their health care needs."

Source:
American Board of Medical Specialties (ABMS)

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Friday, March 25, 2011

RainDance Technologies Launches Two Comprehensive Genetic Screening Research Tools For Identifying Mutations Associated With X-Chromosome And ASD

Error in deserializing body of reply message for operation 'Translate'. The maximum string content length quota (8192) has been exceeded while reading XML data. This quota may be increased by changing the MaxStringContentLength property on the XmlDictionaryReaderQuotas object used when creating the XML reader. Line 1, position 8893.

Main Category: Autism
Also Included In: Genetics
Article Date: 21 Mar 2011 - 4:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
RainDance Technologies, Inc., today announced the commercial availability of the ASDSeq™ and XSeq™ Research Screening Panels. Developed in collaboration with Emory University and Greenwood Genetic Center, the two comprehensive panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD) using next-generation sequencing. The announcement was made at the 20th Annual Clinical Genetics Meeting (ACMG) in Vancouver, British Columbia, Canada.

"The RainDance panels enable us to apply next-generation sequencing more routinely to projects focused on the specific genetic mutations that contribute to autism and other X-linked disorders."

Recent scientific findings indicate there are more than 800 protein-coding genes on the X chromosome, including many that play a role in autism and other developmental disorders1,2. To date, the widespread investigation of these genes has been constrained by the high experimental cost of current methods and inadequate analytic resolution. Commonly used technologies, such as microarrays and real-time PCR, have made it difficult to detect many of the important sequence mutations associated with these complex disorders. The RainDance ASDSeq™ panel and XSeq™ panel are based on the company's proven microdroplet-based targeted sequencing technology, which features the industry's leading coverage for detecting mutations central to understanding these types of disorders.

"Whole-genome and whole-exome sequencing methods are still too expensive; the large amount of data is difficult to manage in a clinical laboratory; and hybridization-based capture methods lack the required genomic coverage and specificity to target many of these important genes," said Madhuri Hegde, Ph.D., FACMG, Senior Director of Emory Genetics Laboratory and Associate Professor in the Department of Human Genetics, Emory University School of Medicine. "The RainDance panels enable us to apply next-generation sequencing more routinely to projects focused on the specific genetic mutations that contribute to autism and other X-linked disorders."

ASDSeq™ Panel

The RainDance ASDSeq Research Screening Panel uses next-generation DNA sequencing to offer more than 92 percent design coverage across 62 genes that contain mutations known to be associated with ASD. Covered gene targets include all exons for each gene, 1 kilobase of the 5-prime promoter region and 3-prime untranslated regions (UTRs), as well as 50 bases upstream and downstream of each exon to capture intron/exon splice junctions. The genes represented in the ASDSeq panel include autosomal (BRAF, FMR1, FOLR1, PNKP, PTPN11, SLC2A1, TCF4 and ZEB2) as well as X-linked (HPRT and NHS) forms of the disorders.

"With an estimated 1.5 million Americans living with the effects of autism, getting to the genetic underpinnings of this complex condition is one of the critical healthcare research challenges of our time," said Michael Friez, Ph.D., Director of Diagnostic Laboratories at the Greenwood Genetic Center. "As an organization dedicated to the practical application of medical advances to the care and treatment of families impacted by genetic disease and birth defects, we are encouraged by the potential contribution these innovative panels will have on the growing number of critical research projects being conducted around the world."

XSeq™ Panel

The RainDance XSeq Research Screening Panel also utilizes next-generation DNA sequencing to offer more than 98 percent coverage of the more than 1,000 genes encoded on the gene-rich human X chromosome3. This includes more than 600 genes that have yet to be associated with a Mendelian disease and all known Mendelian disorder genes. Coverage includes all exons, the 5-prime promoter region and 3-prime UTR for each gene. A few of the commonly sequenced genes represented in the XSeq panel, which can be sequenced together in a single powerful assay method, include ALD, DMD, FMR1, GLA and IL2RG.

"For the first time, we have access to a cost-effective solution that allows us to use next-generation sequencing to simultaneously interrogate more than 1,000 genes on the X chromosome," said Michael Zwick, Ph.D., Assistant Professor, Emory University. "This allows us to generate accurate, consistent and reproducible data at a fraction of the overall sample cost compared to previous sequencing methods."

Roopom Banerjee, CEO of RainDance Technologies, added, "These two research panels are excellent examples of how RainDance is collaborating with leading scientific institutions to bring powerful genetic research solutions to projects that will expand our understanding of complex genetic disorders."

2011 ACMG Annual Clinical Genetics Meeting

RainDance will discuss the ASDSeq and XSeq Research Screening Panels during its Exhibitor Theater presentation at the ACMG meeting on March 18 at 11:35am PT in Theater 1. The company will also be demonstrating its microdroplet platform in its exhibition booth (#533). Emory Genetics Laboratory (#215) and Geenwood Genetic Center (#109) will also be exhibiting at the meeting.

References

1 . Ross et al. (2005). The DNA sequence of the human X chromosome. Nature. Mar 17;434(7031):325-37.

2 . Tarpey et al. (2009). A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet. May;41(5):535-43.

3. Ibid.

Source.
RainDance Technologies, Inc.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here